NEWS & EVENTS

2021

MAY

  • Foldax Announces Successful First Human Use of Tria Biopolymer Mitral Heart Valve
    READ PRESS RELEASE

MARCH

  • Foldax Named Among Fierce Medtech’s “Fierce 15” Companies of 2020
    READ PRESS RELEASE

JANUARY

  • Foldax Biopolymer Shown to Possess Ideal Properties for Heart Valve in New Published Paper
    READ PRESS RELEASE

2020

DECEMBER

  • Foldax Receives FDA IDE Approval for Biopolymeric Mitral Heart Valve Clinical Study
    READ PRESS RELEASE

OCTOBER

  • Foldax Receives FDA Approval to Expand Clinical Study of Novel Biopolymer Aortic Heart Valve
    READ PRESS RELEASE
  • Foldax Named Cardiovascular Device Company of the Year by MedTech Outlook
    READ PRESS RELEASE
  • Foldax Strengthens Scientific and Medical Advisory Boards
    READ PRESS RELEASE

AUGUST

  • Foldax Named a Finalist in the Fierce Innovation Awards – Life Sciences Edition 2020
    READ PRESS RELEASE

JUNE

MAY

  • Tria LifePolymer Heart Valve Honored with 2020 MedTech Medical Device Engineering Breakthrough Award
    READ PRESS RELEASE

MARCH

  • Foldax Completes Enrollment in Tria™ LifePolymer Early Feasibility Study
    READ PRESS RELEASE

FEBRUARY

  • Foldax Tria™ LifePolymer Heart Valve Honored with Best Innovation Award at Cardiovascular Research Technology (CRT) 2020
    READ ARTICLE
  • Best Innovations Competition Winners at Cardiovascular Research Technology (CRT) 2020 by CRTonline.org
    READ ARTICLE

JANUARY

  • The Christ Hospital Becomes Third in the World to Implant Revolutionary Next-Generation Heart Valve
    READ PRESS RELEASE

2019

SEPTEMBER

FEBRUARY

  • Foldax Announces FDA Approval to Begin an Early Feasibility Study of the Tria™ Heart Valve
    READ PRESS RELEASE

2017